AxoGen, Inc.
AXGN
$43.20
$1.433.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.59% | -0.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.59% | -0.30% | |||
| Cost of Revenue | -1.46% | 9.98% | |||
| Gross Profit | 4.01% | -3.44% | |||
| SG&A Expenses | -0.72% | 14.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.73% | 19.78% | |||
| Operating Income | 71.02% | -611.09% | |||
| Income Before Tax | -48.86% | -1,958.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -48.86% | -1,958.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -48.86% | -1,958.19% | |||
| EBIT | 71.02% | -611.09% | |||
| EBITDA | 85.99% | -320.90% | |||
| EPS Basic | -35.43% | -1,944.08% | |||
| Normalized Basic EPS | 81.11% | -1,944.21% | |||
| EPS Diluted | -35.57% | -2,903.00% | |||
| Normalized Diluted EPS | 81.11% | -2,046.67% | |||
| Average Basic Shares Outstanding | 9.93% | 0.93% | |||
| Average Diluted Shares Outstanding | 9.93% | -4.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||